Christopher S Anderson1,2, Chin-Yi Chu1,2, Qian Wang1,2, Jared A Mereness1,2, Yue Ren1,2, Kathy Donlon1,2, Soumyaroop Bhattacharya1,2, Ravi S Misra1, Edward E Walsh3,4, Gloria S Pryhuber1, Thomas J Mariani5,6. 1. Division of Neonatology, Department of Pediatrics, University of Rochester Medical Center, Rochester, NY, USA. 2. Program in Pediatric Molecular and Personalized Medicine, Department of Pediatrics, University of Rochester Medical Center, Rochester, NY, USA. 3. Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA. 4. Department of Medicine, Rochester General Hospital, Rochester, NY, USA. 5. Division of Neonatology, Department of Pediatrics, University of Rochester Medical Center, Rochester, NY, USA. Tom_Mariani@urmc.rochester.edu. 6. Program in Pediatric Molecular and Personalized Medicine, Department of Pediatrics, University of Rochester Medical Center, Rochester, NY, USA. Tom_Mariani@urmc.rochester.edu.
Abstract
BACKGROUND: Data on the host factors that contribute to infection of young children by respiratory syncytial virus (RSV) are limited. The human chemokine receptor, CX3CR1, has recently been implicated as an RSV receptor. Here we evaluate a role for CX3CR1 in pediatric lung RSV infections. METHODS: CX3CR1 transcript levels in the upper and lower pediatric airways were assessed. Tissue localization and cell-specific expression was confirmed using in situ hybridization and immunohistochemistry. The role of CX3CR1 in RSV infection was also investigated using a novel physiological model of pediatric epithelial cells. RESULTS: Low levels of CX3CR1 transcript were often, but not always, expressed in both upper (62%) and lower airways (36%) of pediatric subjects. CX3CR1 transcript and protein expression was detected in epithelial cells of normal human pediatric lung tissues. CX3CR1 expression was readily detected on primary cultures of differentiated pediatric/infant human lung epithelial cells. RSV demonstrated preferential infection of CX3CR1-positive cells, and blocking CX3CR1/RSV interaction significantly decreased viral load. CONCLUSION: CX3CR1 is present in the airways of pediatric subjects where it may serve as a receptor for RSV infection. Furthermore, CX3CR1 appears to play a mechanistic role in mediating viral infection of pediatric airway epithelial cells in vitro.
BACKGROUND: Data on the host factors that contribute to infection of young children by respiratory syncytial virus (RSV) are limited. The humanchemokine receptor, CX3CR1, has recently been implicated as an RSV receptor. Here we evaluate a role for CX3CR1 in pediatric lung RSV infections. METHODS:CX3CR1 transcript levels in the upper and lower pediatric airways were assessed. Tissue localization and cell-specific expression was confirmed using in situ hybridization and immunohistochemistry. The role of CX3CR1 in RSV infection was also investigated using a novel physiological model of pediatric epithelial cells. RESULTS: Low levels of CX3CR1 transcript were often, but not always, expressed in both upper (62%) and lower airways (36%) of pediatric subjects. CX3CR1 transcript and protein expression was detected in epithelial cells of normal human pediatric lung tissues. CX3CR1 expression was readily detected on primary cultures of differentiated pediatric/infanthuman lung epithelial cells. RSV demonstrated preferential infection of CX3CR1-positive cells, and blocking CX3CR1/RSV interaction significantly decreased viral load. CONCLUSION:CX3CR1 is present in the airways of pediatric subjects where it may serve as a receptor for RSV infection. Furthermore, CX3CR1 appears to play a mechanistic role in mediating viral infection of pediatric airway epithelial cells in vitro.
Authors: Youngjoo Choi; Caleb S Mason; Les P Jones; Jackelyn Crabtree; Patricia A Jorquera; Ralph A Tripp Journal: Viral Immunol Date: 2012-05-02 Impact factor: 2.257
Authors: Christopher S Anderson; Tatiana Chirkova; Christopher G Slaunwhite; Xing Qiu; Edward E Walsh; Larry J Anderson; Thomas J Mariani Journal: J Virol Date: 2021-03-17 Impact factor: 5.103
Authors: Phillip Ziegler; Yarong Tian; Yulong Bai; Sanna Abrahamsson; Alan Bäckerholm; Alex S Reznik; Anthony Green; John A Moore; Stella E Lee; Michael M Myerburg; Hyun Jung Park; Ka-Wei Tang; Kathy Ho Yen Shair Journal: PLoS Pathog Date: 2021-04-29 Impact factor: 6.823
Authors: Peter Mastrangelo; Allysia A Chin; Stephanie Tan; Amy H Jeon; Cameron A Ackerley; Karen K Siu; Jeffrey E Lee; Richard G Hegele Journal: Viruses Date: 2021-02-08 Impact factor: 5.048
Authors: Gia Green; Sara M Johnson; Heather Costello; Kelsey Brakel; Olivia Harder; Antonius G Oomens; Mark E Peeples; Hong M Moulton; Stefan Niewiesk Journal: J Virol Date: 2021-07-26 Impact factor: 5.103
Authors: Andreas Frey; Lars P Lunding; Johanna C Ehlers; Markus Weckmann; Ulrich M Zissler; Michael Wegmann Journal: Front Immunol Date: 2020-04-28 Impact factor: 7.561